Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease
Igawa, Satoshi, Yokoba, Masanori, Takakura, Akira, Hosotani, Shinji, Nakahara, Yoshiro, Sato, Takashi, Mitsufuji, Hisashi, Sasaki, Jiichiro, Naoki, Katsuhiko
Published in Investigational new drugs (01.02.2022)
Published in Investigational new drugs (01.02.2022)
Get full text
Journal Article
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab
Fukui, Tomoya, Hosotani, Shinji, Soda, Itaru, Ozawa, Takahiro, Kusuhara, Seiichiro, Kakegawa, Mikiko I., Kasajima, Masashi, Hiyoshi, Yasuhiro, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Ishiyama, Hiromichi, Naoki, Katsuhiko
Published in Thoracic cancer (01.04.2020)
Published in Thoracic cancer (01.04.2020)
Get full text
Journal Article
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma
Manaka, Hiroya, Igawa, Satoshi, Yamamoto, Michiko, Oguri, Akito, Manabe, Hideaki, Kasajima, Masashi, Kusuhara, Seiichiro, Hosotani, Shinji, Nakahara, Yoshiro, Sato, Takashi, Fukui, Tomoya, Hisashi, Mitsufuji, Sasaki, Jiichiro, Naoki, Katsuhiko
Published in Investigational new drugs (01.02.2023)
Published in Investigational new drugs (01.02.2023)
Get full text
Journal Article
Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study
Sone, Hideyuki, Igawa, Satoshi, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Hosotani, Shinji, Ohe, Shuntaro, Ito, Hiroki, Kaizuka, Nobuki, Manaka, Hiroya, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Published in Thoracic cancer (01.10.2018)
Published in Thoracic cancer (01.10.2018)
Get full text
Journal Article
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease
Igawa, Satoshi, Nishinarita, Noriko, Takakura, Akira, Ozawa, Takahiro, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Hosotani, Shinji, Sone, Hideyuki, Nakahara, Yoshiro, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Published in Cancer management and research (01.01.2018)
Published in Cancer management and research (01.01.2018)
Get full text
Journal Article
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung
Igawa, Satoshi, Nishinarita, Noriko, Takakura, Akira, Ozawa, Takahiro, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Hosotani, Shinji, Sone, Hideyuki, Nakahara, Yoshiro, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Katsuhiko, Naoki
Published in Cancer management and research (01.01.2018)
Published in Cancer management and research (01.01.2018)
Get full text
Journal Article